Stryker (SYK) EPS (Basic) Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.51% |
| Dec 31, 2025 | 7.92% |
| Sep 30, 2025 | 6.27% |
| Jun 30, 2025 | 65.84% |
| Mar 31, 2025 | 5.31% |
| Dec 31, 2024 | -5.92% |
| Sep 30, 2024 | 11.95% |
| Jun 30, 2024 | 10.96% |
| Mar 31, 2024 | 13.48% |
| Dec 31, 2023 | -11.42% |
| Sep 30, 2023 | 2.87% |
| Jun 30, 2023 | 10.01% |
| Mar 31, 2023 | 5.74% |
| Dec 31, 2022 | 33.51% |
| Sep 30, 2022 | 13.24% |
| Jun 30, 2022 | 10.71% |
| Mar 31, 2022 | -6.29% |
| Dec 31, 2021 | 5.17% |
| Sep 30, 2021 | 4.25% |
| Jun 30, 2021 | 9.01% |
| Mar 31, 2021 | -5.83% |
| Dec 31, 2020 | 1.67% |
| Sep 30, 2020 | 15.72% |
| Jun 30, 2020 | -17.20% |
| Mar 31, 2020 | 17.47% |
| Dec 31, 2019 | 23.33% |
| Sep 30, 2019 | 50.61% |
| Jun 30, 2019 | 30.56% |
| Mar 31, 2019 | 42.08% |
| Dec 31, 2018 | 40.17% |
| Sep 30, 2018 | 42.38% |
| Jun 30, 2018 | 16.66% |
| Mar 31, 2018 | 8.08% |
| Dec 31, 2017 | -23.98% |
| Sep 30, 2017 | 4.52% |
| Jun 30, 2017 | 4.12% |
| Mar 31, 2017 | 5.28% |
| Dec 31, 2016 | 5.31% |
| Sep 30, 2016 | 2.25% |
| Jun 30, 2016 | 4.98% |
| Mar 31, 2016 | 6.45% |
| Dec 31, 2015 | 13.13% |
| Sep 30, 2015 | -1.21% |
| Jun 30, 2015 | 5.39% |
| Mar 31, 2015 | -6.14% |
| Dec 31, 2014 | -2.46% |
| Sep 30, 2014 | -22.71% |
| Jun 30, 2014 | -14.17% |
| Mar 31, 2014 | -23.18% |